Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
NCT00241124 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1099
Last updated 2011-11-23
Summary
A study comparing the antihypertensives Valsartan and Lisinporil when doses are in the morning and comparing a morning dose of Valsartan with an evening dose.
Conditions
Interventions
- DRUG
-
valsartan
- DRUG
-
lisinopril
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-04-30
- Primary Completion
- 2005-06-30
- Completion
- 2005-06-30
Countries
- Germany
More Related Trials
-
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
NCT00394745 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
NCT00219102 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
NCT00241085 ·Status: COMPLETED ·Phase: PHASE4
-
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
NCT00550095 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
NCT00219050 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
NCT00170937 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
NCT01095822 ·Status: UNKNOWN ·Phase: PHASE4
-
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
NCT00809926 ·Status: COMPLETED ·Phase: PHASE4
-
To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 ·Status: COMPLETED ·Phase: PHASE4
-
Chronopharmacology of Valsartan in Normotensive Subjects
NCT02631031 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
NCT01122251 ·Status: COMPLETED ·Phase: PHASE2
-
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
NCT00657241 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
NCT00280540 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure
NCT00260923 ·Status: COMPLETED ·Phase: PHASE3
-
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT00922441 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
NCT00171119 ·Status: TERMINATED ·Phase: PHASE4
-
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
NCT01609959 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
NCT00333489 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
NCT00758524 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.
NCT00219128 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
NCT00464880 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
NCT00699192 ·Status: COMPLETED ·Phase: PHASE3